Literature DB >> 22249799

Primary epidermoid carcinoma of the breast presenting as a breast abscess and sepsis.

Andrea Pires Damin1, Fernanda Costa Nascimento, João Batista Andreola, Talita Haubert Cerutti, Adriana Roehe, Daniel Carvalho Damin.   

Abstract

CONTEXT: Squamous cell carcinoma (SCC) of the breast is an extremely rare form of cancer, accounting for approximately 0.04% of all malignant breast tumors. To date, only a limited number of cases of SCC of the breast have been reported, and most of them presented like the usual breast carcinomas. CASE REPORT: A 39-year-old woman presented with a large breast abscess and signs of sepsis. After surgical debridement of the lesion, histopathological examination of the abscess capsule revealed the presence of SCC of the breast. The definitive treatment for the tumor consisted of modified radical mastectomy with resection of the residual lesion in the right breast.
CONCLUSIONS: This unusual case illustrates how an apparently benign disorder such as a breast abscess might be related to a clinically occult malignancy. A review of the literature on SCC of the breast is presented.

Entities:  

Mesh:

Year:  2011        PMID: 22249799     DOI: 10.1590/s1516-31802011000600009

Source DB:  PubMed          Journal:  Sao Paulo Med J        ISSN: 1516-3180            Impact factor:   1.044


  3 in total

Review 1.  [Squamous cell carcinoma of the breast: report of 3 cases and literature review].

Authors:  Fatima Zohra Fdili Alaoui; Saad Benkirane; Hekmat Chaara; Hakima Bouguern; Moulay Abdilah Melhouf
Journal:  Pan Afr Med J       Date:  2012-06-21

Review 2.  Primary squamous cell carcinoma of the breast: a case report and review of literature.

Authors:  Youssef Seddik; Sami Aziz Brahmi; Said Afqir
Journal:  Pan Afr Med J       Date:  2015-02-18

3.  Prognostic factors for breast cancer squamous cell carcinoma and nomogram development for prediction: population-based research.

Authors:  Zhiyuan Cheng; Tao Han; Xiaotian Zhang; Xizhou Li; Hengyu Li; Jia Gu
Journal:  Transl Cancer Res       Date:  2019-09       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.